chr1:58780791:> Detail (hg38)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr1:59,246,463-59,249,719 |
| hg38 | chr1:58,780,791-58,784,047 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.001 | squamous cell carcinoma | NA | BeFree | Detail | |
| <0.001 | Cardiovascular Diseases | NA | BeFree | Detail | |
| 0.120 | Neoplastic Cell Transformation | NA | CTD_human | Detail | |
| <0.001 | cerebral infarction | NA | BeFree | Detail | |
| 0.120 | brain ischemia | NA | CTD_human | Detail | |
| 0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
| <0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
| 0.123 | Colonic Neoplasms | NA | CTD_human,LHGDN | Detail | |
| 0.002 | colorectal carcinoma | NA | BeFree | Detail | |
| <0.001 | Condylomata Acuminata | NA | BeFree | Detail | |
| 0.003 | Crohn Disease | NA | BeFree,GAD | Detail | |
| <0.001 | cystic fibrosis | NA | BeFree | Detail | |
| 0.080 | depressive disorder | NA | RGD | Detail | |
| <0.001 | dermatitis | Here we review the present evidence and the underlying mechanisms of how Jun/AP-... | BeFree | 26458100 | Detail |
| <0.001 | Dermatitis, Atopic | Notably, Notch1 is a repressor of activator protein-1 (AP-1), which is upregulat... | BeFree | 24853951 | Detail |
| 0.003 | Diabetic Nephropathy | NA | LHGDN | Detail | |
| <0.001 | eclampsia | NFAT-1, STAT-1 and AP-1 might be the central transcription factors in the pathog... | BeFree | 24931237 | Detail |
| <0.001 | Eczema | Notably, Notch1 is a repressor of activator protein-1 (AP-1), which is upregulat... | BeFree | 24853951 | Detail |
| 0.003 | Endometrial Neoplasms | NA | LHGDN | Detail | |
| <0.001 | Enteritis | NA | BeFree | Detail | |
| <0.001 | fibrosarcoma | NA | BeFree | Detail | |
| <0.001 | gastritis | NA | BeFree | Detail | |
| <0.001 | gastroesophageal reflux disease | All results suggested that EGR1, JUN, FOS may play important roles in the develo... | BeFree | 24706321 | Detail |
| <0.001 | glioblastoma | NA | BeFree | Detail | |
| 0.003 | Glioma | NA | BeFree,LHGDN | Detail | |
| <0.001 | glomerulonephritis | NA | BeFree | Detail | |
| <0.001 | cardiac arrest | NA | BeFree | Detail | |
| 0.120 | Heat Stroke | NA | CTD_human | Detail | |
| 0.120 | Hemangiosarcoma | NA | CTD_human | Detail | |
| 0.003 | hepatitis | NA | LHGDN | Detail | |
| <0.001 | HIV Infections | NA | BeFree | Detail | |
| 0.005 | Hodgkin Disease | NA | LHGDN | Detail | |
| <0.001 | hyperglycemia | NA | BeFree | Detail | |
| 0.080 | Hypertensive disease | NA | BeFree,RGD | Detail | |
| 0.003 | pulmonary hypertension | NA | BeFree,LHGDN | Detail | |
| 0.120 | Intestinal Polyps | NA | CTD_human | Detail | |
| 0.080 | Kidney Neoplasm | NA | RGD | Detail | |
| <0.001 | Polycystic Kidney Diseases | NA | BeFree | Detail | |
| <0.001 | leukemia | NA | BeFree | Detail | |
| <0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
| <0.001 | Leukemia, Myelocytic, Acute | NA | BeFree | Detail | |
| 0.003 | myeloid leukemia | NA | BeFree,LHGDN | Detail | |
| <0.001 | Leukemia, T-Cell | NA | BeFree | Detail | |
| 0.002 | Adult T-Cell Lymphoma/Leukemia | NA | BeFree | Detail | |
| <0.001 | liposarcoma | NA | BeFree | Detail | |
| <0.001 | Liver diseases | NA | BeFree | Detail | |
| 0.121 | Liver neoplasms | NA | BeFree,CTD_human | Detail | |
| <0.001 | Lung diseases | NA | BeFree | Detail | |
| 0.123 | Lung Neoplasms | NA | CTD_human,LHGDN | Detail | |
| 0.004 | Lupus Erythematosus, Systemic | NA | BeFree,LHGDN | Detail | |
| <0.001 | Lyme disease | NA | BeFree | Detail | |
| 0.004 | lymphoma | Furthermore, using a combination of RNA interference and gene expression profili... | BeFree,LHGDN | 25533033 | Detail |
| 0.001 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
| 0.003 | melanoma | In summary, there are a variety of mechanisms underlying the induction of c-Jun ... | BeFree | 24315690 | Detail |
| <0.001 | Monoclonal Gammopathy of Undetermined Significance | NA | BeFree | Detail | |
| <0.001 | multiple myeloma | NA | BeFree | Detail | |
| 0.007 | Neoplasm Metastasis | Our results suggest that the AP-1/miR-101 feedback loop may prevent the excessiv... | BeFree,LHGDN | 25260594 | Detail |
| <0.001 | neuroblastoma | NA | BeFree | Detail | |
| <0.001 | obesity | NA | BeFree | Detail | |
| <0.001 | ocular hypertension | NA | BeFree | Detail | |
| <0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
| 0.126 | osteosarcoma | NA | BeFree,CTD_human,LHGDN | Detail | |
| 0.001 | ovarian carcinoma | NA | BeFree | Detail | |
| 0.005 | Pancreatic Neoplasm | NA | LHGDN | Detail | |
| 0.120 | Peripheral neuropathy | NA | CTD_human | Detail | |
| <0.001 | pneumonia | NA | BeFree | Detail | |
| <0.001 | polyps | NA | BeFree | Detail | |
| 0.011 | Prostatic Neoplasms | NA | LHGDN | Detail | |
| <0.001 | pseudomyxoma peritonei | Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive... | BeFree | 24369359 | Detail |
| 0.004 | psoriasis | NA | BeFree,LHGDN | Detail | |
| <0.001 | pulmonary emphysema | NA | BeFree | Detail | |
| 0.120 | Reperfusion Injury | NA | CTD_human | Detail | |
| <0.001 | Respiratory Syncytial Virus Infections | In conclusion, the results of the present study indicate that the TLR4 signaling... | BeFree | 24968899 | Detail |
| <0.001 | Rotavirus Infections | NA | BeFree | Detail | |
| 0.002 | Salmonella infections | NA | GAD | Detail | |
| <0.001 | sarcoidosis | NA | BeFree | Detail | |
| <0.001 | schizophrenia | NA | BeFree | Detail | |
| <0.001 | systemic scleroderma | NA | BeFree | Detail | |
| <0.001 | scrub typhus | NA | BeFree | Detail | |
| <0.001 | Septicemia | NA | BeFree | Detail | |
| 0.120 | status epilepticus | NA | CTD_human | Detail | |
| 0.125 | Stomach Neoplasms | NA | CTD_human,LHGDN | Detail | |
| <0.001 | Thyroid Diseases | NA | BeFree | Detail | |
| <0.001 | Unipolar Depression | Eighty percent of these genes were functionally associated with a key stress res... | BeFree | 25734512 | Detail |
| <0.001 | Vascular Diseases | NA | BeFree | Detail | |
| <0.001 | Virus Diseases | NA | BeFree | Detail | |
| <0.001 | diffuse large B-cell lymphoma | Mechanistically, genome-wide mapping of PRDM11 binding sites coupled with transc... | BeFree | 25499759 | Detail |
| 0.003 | Lymphoma, T-Cell, Cutaneous | NA | BeFree,LHGDN | Detail | |
| 0.003 | Polycystic Kidney, Autosomal Dominant | NA | BeFree,LHGDN | Detail | |
| 0.002 | Arthritis, Reactive | NA | GAD | Detail | |
| <0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of lung (disorder) | NA | BeFree | Detail | |
| <0.001 | Tumor Progression | In summary, there are a variety of mechanisms underlying the induction of c-Jun ... | BeFree | 24315690 | Detail |
| <0.001 | Liposarcoma, Dedifferentiated | NA | BeFree | Detail | |
| <0.001 | Ki-1+ Anaplastic Large Cell Lymphoma | Here, we discuss the role of AP-1 in the pathogenesis of ALCL and provide an ove... | BeFree | 25961698 | Detail |
| 0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Medullary carcinoma of thyroid | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of lung | NA | BeFree | Detail | |
| 0.003 | Hyperoxia | NA | LHGDN | Detail | |
| <0.001 | Sepsis | NA | BeFree | Detail | |
| <0.001 | Severe myopia | NA | BeFree | Detail | |
| <0.001 | Erythroblastosis | NA | BeFree | Detail | |
| <0.001 | Cancer of Head and Neck | NA | BeFree | Detail | |
| <0.001 | Condyloma | NA | BeFree | Detail | |
| 0.001 | cervix carcinoma | NA | BeFree | Detail | |
| <0.001 | Restenosis | NA | BeFree | Detail | |
| <0.001 | Carcinoid tumor no ICD-O subtype | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of colon | NA | BeFree | Detail | |
| 0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| <0.001 | Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | NA | BeFree | Detail | |
| 0.002 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
| <0.001 | Non-alcoholic Fatty Liver Disease | NA | BeFree | Detail | |
| <0.001 | Idiopathic crescentic glomerulonephritis | NA | BeFree | Detail | |
| 0.120 | Mercury Poisoning, Nervous System | NA | CTD_human | Detail | |
| <0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
| 0.008 | Carcinogenesis | NA | BeFree | Detail | |
| 0.003 | prostate carcinoma | NA | BeFree | Detail | |
| <0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
| 0.004 | breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of lung | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
| 0.002 | colon carcinoma | NA | BeFree | Detail | |
| 0.002 | stomach carcinoma | NA | BeFree | Detail | |
| <0.001 | Carcinoma of bladder | The DEGs encoding activator protein 1 (AP-1), nuclear factor of activated T-cell... | BeFree | 25050631 | Detail |
| <0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Helicobacter pylori infection | NA | BeFree | Detail | |
| <0.001 | Invasive breast carcinoma | NA | BeFree | Detail | |
| <0.001 | Cerebral Ischemia | NA | BeFree | Detail | |
| <0.001 | ovarian neoplasm | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of ovary | NA | BeFree,GAD | Detail | |
| <0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
| <0.001 | sarcoma | NA | BeFree | Detail | |
| <0.001 | major depressive disorder | Eighty percent of these genes were functionally associated with a key stress res... | BeFree | 25734512 | Detail |
| 0.134 | Mammary Neoplasms | NA | BeFree,CTD_human,LHGDN | Detail | |
| <0.001 | Hepatocarcinogenesis | NA | BeFree | Detail | |
| <0.001 | Tumor Angiogenesis | NA | BeFree | Detail | |
| 0.001 | Tumor Promotion | NA | BeFree | Detail | |
| 0.003 | colorectal cancer | NA | BeFree | Detail | |
| <0.001 | Glucocorticoid Receptor Deficiency | NA | BeFree | Detail | |
| 0.080 | PULMONARY DISEASE, CHRONIC OBSTRUCTIVE, SEVERE EARLY-ONSET | NA | MGD | Detail | |
| <0.001 | Corneal dystrophy, Fuchs' endothelial, 1 | NA | BeFree | Detail | |
| 0.080 | Emphysema, Hereditary Pulmonary | NA | MGD | Detail | |
| <0.001 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree | Detail | |
| 0.128 | liver carcinoma | miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN ex... | BeFree,CTD_human,LHGDN | 25230788 | Detail |
| 0.128 | liver carcinoma | We showed that CREBH activated by HBx interacted with HBx protein, leading to a ... | BeFree,CTD_human,LHGDN | 25428452 | Detail |
| 0.128 | liver carcinoma | Mucin1 mediates autocrine transforming growth factor beta signaling through acti... | BeFree,CTD_human,LHGDN | 25526895 | Detail |
| <0.001 | Oropharyngeal Carcinoma | Integrated omic analysis of oropharyngeal carcinomas reveals human papillomaviru... | BeFree | 25271301 | Detail |
| <0.001 | Nasopharyngeal carcinoma | RNAi-mediated knockdown of the c-jun gene sensitizes radioresistant human nasoph... | BeFree | 25571870 | Detail |
| 0.120 | Juvenile arthritis | NA | CTD_human | Detail | |
| <0.001 | aortic valve disease 2 | NA | BeFree | Detail | |
| <0.001 | intellectual disability | NA | BeFree | Detail | |
| <0.001 | Experimental Organism Basal Cell Carcinoma | NA | BeFree | Detail | |
| <0.001 | bronchiolitis | SNPs in the innate immune genes VDR (rs10735810; P=.0017), JUN (rs11688; P=.0093... | BeFree | 17703412 | Detail |
| 0.005 | adenocarcinoma | NA | LHGDN | Detail | |
| <0.001 | Alzheimer's disease | NA | BeFree | Detail | |
| <0.001 | Anaplasia | NA | BeFree | Detail | |
| <0.001 | Anemia, Sickle Cell | NA | BeFree | Detail | |
| 0.005 | Anoxia | NA | LHGDN | Detail | |
| <0.001 | aortic aneurysm | NA | BeFree | Detail | |
| <0.001 | aortic valve stenosis | NA | BeFree | Detail | |
| <0.001 | arthritis | NA | BeFree | Detail | |
| 0.004 | rheumatoid arthritis | Our findings suggest that overexpression of peroxiredoxin 6 might promote develo... | BeFree,LHGDN | 26211509 | Detail |
| 0.002 | asthma | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of urinary bladder | The DEGs encoding activator protein 1 (AP-1), nuclear factor of activated T-cell... | BeFree | 25050631 | Detail |
| <0.001 | Brain Diseases | NA | BeFree | Detail | |
| 0.007 | Malignant neoplasm of breast | NA | BeFree,GAD | Detail | |
| <0.001 | bronchiolitis | NA | BeFree | Detail | |
| 0.002 | Campylobacter infection | NA | GAD | Detail | |
| <0.001 | candidiasis | NA | BeFree | Detail | |
| <0.001 | Carcinoid Tumor | NA | BeFree | Detail | |
| 0.002 | Malignant tumor of colon | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
| <0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail | |
| <0.001 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Here we review the present evidence and the underlying mechanisms of how Jun/AP-1 proteins control s... | DisGeNET | Detail |
| Notably, Notch1 is a repressor of activator protein-1 (AP-1), which is upregulated in AD epidermis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NFAT-1, STAT-1 and AP-1 might be the central transcription factors in the pathogenesis of pre-eclamp... | DisGeNET | Detail |
| Notably, Notch1 is a repressor of activator protein-1 (AP-1), which is upregulated in AD epidermis. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| All results suggested that EGR1, JUN, FOS may play important roles in the development of GERD. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Furthermore, using a combination of RNA interference and gene expression profiling, we identified Ju... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In summary, there are a variety of mechanisms underlying the induction of c-Jun protein expression a... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our results suggest that the AP-1/miR-101 feedback loop may prevent the excessive activation of meta... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling a... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In conclusion, the results of the present study indicate that the TLR4 signaling pathway, in conjunc... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Eighty percent of these genes were functionally associated with a key stress response signalling cas... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Mechanistically, genome-wide mapping of PRDM11 binding sites coupled with transcriptome sequencing i... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| In summary, there are a variety of mechanisms underlying the induction of c-Jun protein expression a... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Here, we discuss the role of AP-1 in the pathogenesis of ALCL and provide an overview of pathologica... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The DEGs encoding activator protein 1 (AP-1), nuclear factor of activated T-cells (NFAT) proteins, n... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Eighty percent of these genes were functionally associated with a key stress response signalling cas... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatoce... | DisGeNET | Detail |
| We showed that CREBH activated by HBx interacted with HBx protein, leading to a synergistic effect o... | DisGeNET | Detail |
| Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-t... | DisGeNET | Detail |
| Integrated omic analysis of oropharyngeal carcinomas reveals human papillomavirus (HPV)-dependent re... | DisGeNET | Detail |
| RNAi-mediated knockdown of the c-jun gene sensitizes radioresistant human nasopharyngeal carcinoma c... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| SNPs in the innate immune genes VDR (rs10735810; P=.0017), JUN (rs11688; P=.0093), IFNA5 (rs10757212... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Our findings suggest that overexpression of peroxiredoxin 6 might promote development of RA through ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The DEGs encoding activator protein 1 (AP-1), nuclear factor of activated T-cells (NFAT) proteins, n... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- dbSNP
- rs10735810 dbSNP
- Genome
- hg38
- Position
- chr1:58,780,791-58,784,047
- Variant Type
- snv
Genome browser